FluoGuide intends to carry out a directed share issue of approximately SEK 75 million
Copenhagen, Denmark, 17:31 CEST, 11 May 2021 – FluoGuide A/S (publ), a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”) (Nasdaq First North Growth Market: FLUO) hereby announces its intention to carry out a directed share issue of approximately SEK 75 million to Swedish and international institutional investors (the “Directed Share Issue”). The Company has retained Skandinaviska Enskilda Banken AB and ABG Sundal Collier to act as Joint Bookrunners (the “Joint Bookrunners”) in connection with the directed share issue. Sedermera Fondkommission has been